Study Stopped
Interim analysis shown futility to continue due to lack of benefit.
Comparison Between NICOM-Cheetah and Flotrac-Vigileo for Cardiac Output Monitoring.
An Observational Study Comparing NICOM-Cheetah Versus Flotrac-Vigileo for Cardiac Output Monitoring in the Surgical Intensive Care Unit.
2 other identifiers
observational
26
1 country
1
Brief Summary
Cardiac output (CO) monitoring is an important tool in critically ill patients with haemodynamic instability. Traditionally, this has been accomplished using the pulmonary artery catheter (PAC). However, its use has been associated with various complications such as pneumothorax, arrhythmia, infection, pulmonary valve injury and embolism. This has led to the development of various minimally invasive cardiac output monitoring devices such as the oesophageal Doppler, PiCCO®, NiCCO® and FloTrac®. These devices however have their inherent limitations and though minimally invasive, are still not without risks to the patient. More recently a completely non-invasive CO monitoring device, NICOM Cheetah® has been introduced. Its use is based on thoracic bioreactance and it involves placement of 4 electrodes on either side of the thorax and it analyses changes in the phase of electrical voltage signal to the current applied across the thorax. Initial validation studies on the NICOM Cheetah® device revealed promising results. This study intends to compare cardiac output monitoring capabilities of the NICOM Cheetah® device using the FloTrac® CO monitor as a reference.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Aug 2018
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 3, 2018
CompletedFirst Posted
Study publicly available on registry
January 9, 2018
CompletedStudy Start
First participant enrolled
August 10, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 5, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 5, 2021
CompletedResults Posted
Study results publicly available
March 3, 2021
CompletedMay 11, 2021
May 1, 2021
2.4 years
January 3, 2018
January 26, 2021
May 10, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Degree of Disagreement, %
Comparison of cardiac output monitoring capabilities of the NICOM Cheetah® versus the FloTrac®. Cardiac output defined as the amount of blood the heart pumps through the circulatory system in a minute. Bland-Altman analysis used to compare the level of disagreement between the 2 devices, %.
10 hours of data collected for each participant
Study Arms (2)
NICOM Cheetah®
Patients will be treated as per department protocols and no additional intervention will be performed. Each patient will have an arterial catheter inserted as per our usual practice. All patients will have the FloTrac® connected to the arterial catheter (standard of care in CGH SICU) and the NICOM Cheetah® electrodes placed on the skin across the anterior thoracic wall. The NICOM CO monitor involves the application of non-invasive sensor strips. In this study, it will be applied to patients receiving the FloTrac (standard of care), on top of the standard care of monitoring with Flotrac.
FloTrac®
Same patient population as the NICOM Cheetah® group as described above as all patients will have the FloTrac® connected to the arterial catheter (standard of care in CGH SICU) and the NICOM Cheetah® electrodes placed on the skin across the anterior thoracic wall. The FloTrac CO monitor is the current standard of care for cardiac output monitoring in the SICU of CGH. All patients deemed to require cardiac output monitoring will receive the FloTrac (as per departmental practice).
Interventions
Patients will be treated as per department protocols and no additional intervention will be performed
Eligibility Criteria
Patients admitted to the surgical intensive care unit (SICU) who are deemed to require cardiac output monitoring by the treating intensivist
You may qualify if:
- Patients who are deemed to require cardiac output monitoring.
- Patients 21 years old and above
- American Society of Anesthesiologist (ASA) physical status 1 to 4
You may not qualify if:
- Patients who are not on mechanical ventilation.
- Patients who are not in sinus rhythm.
- Patients with allergy to adhesive tapes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Surgical Intensive Care Unit, Changi General Hospital
Singapore, 529889, Singapore
Related Publications (4)
Squara P, Denjean D, Estagnasie P, Brusset A, Dib JC, Dubois C. Noninvasive cardiac output monitoring (NICOM): a clinical validation. Intensive Care Med. 2007 Jul;33(7):1191-1194. doi: 10.1007/s00134-007-0640-0. Epub 2007 Apr 26.
PMID: 17458538BACKGROUNDRaval NY, Squara P, Cleman M, Yalamanchili K, Winklmaier M, Burkhoff D. Multicenter evaluation of noninvasive cardiac output measurement by bioreactance technique. J Clin Monit Comput. 2008 Apr;22(2):113-9. doi: 10.1007/s10877-008-9112-5. Epub 2008 Mar 14.
PMID: 18340540BACKGROUNDMarque S, Cariou A, Chiche JD, Squara P. Comparison between Flotrac-Vigileo and Bioreactance, a totally noninvasive method for cardiac output monitoring. Crit Care. 2009;13(3):R73. doi: 10.1186/cc7884. Epub 2009 May 19.
PMID: 19454009BACKGROUNDMehta Y, Arora D. Newer methods of cardiac output monitoring. World J Cardiol. 2014 Sep 26;6(9):1022-9. doi: 10.4330/wjc.v6.i9.1022.
PMID: 25276302BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Serene Yeow, Senior Executive, Clinical Trials and Research Unit
- Organization
- Changi General Hospital
Study Officials
- PRINCIPAL INVESTIGATOR
See Seong Chang, MBBS, MMed
Changi General Hospital
- PRINCIPAL INVESTIGATOR
Louis Ng, MBBS, ANZCA
Changi General Hospital
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 2 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Consultant
Study Record Dates
First Submitted
January 3, 2018
First Posted
January 9, 2018
Study Start
August 10, 2018
Primary Completion
January 5, 2021
Study Completion
January 5, 2021
Last Updated
May 11, 2021
Results First Posted
March 3, 2021
Record last verified: 2021-05
Data Sharing
- IPD Sharing
- Will not share
IPD will not be available to anyone else other than the investigators of this study